Shinpoong Pharmaceutical Co.,Ltd

KOSE:A019170 Stock Report

Market Cap: ₩529.5b

Shinpoong PharmaceuticalLtd Dividends and Buybacks

Dividend criteria checks 0/6

Shinpoong PharmaceuticalLtd does not currently pay a dividend.

Key information

0%

Dividend yield

n/a

Buyback Yield

Total Shareholder Yieldn/a
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per share₩100.000
Payout ratio0%

Recent dividend and buyback updates

Recent updates

Does Shinpoong PharmaceuticalLtd (KRX:019170) Have A Healthy Balance Sheet?

Nov 13
Does Shinpoong PharmaceuticalLtd (KRX:019170) Have A Healthy Balance Sheet?

Shinpoong Pharmaceutical Co.,Ltd's (KRX:019170) 30% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Sep 11
Shinpoong Pharmaceutical Co.,Ltd's (KRX:019170) 30% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Is Shinpoong PharmaceuticalLtd (KRX:019170) Weighed On By Its Debt Load?

Aug 08
Is Shinpoong PharmaceuticalLtd (KRX:019170) Weighed On By Its Debt Load?

Shinpoong Pharmaceutical Co.,Ltd (KRX:019170) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely

Apr 24
Shinpoong Pharmaceutical Co.,Ltd (KRX:019170) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely

Do Shin Poong Pharm.Co.Ltd's (KRX:019170) Earnings Warrant Your Attention?

Mar 07
Do Shin Poong Pharm.Co.Ltd's (KRX:019170) Earnings Warrant Your Attention?

Declining Stock and Decent Financials: Is The Market Wrong About Shin Poong Pharm.Co.,Ltd. (KRX:019170)?

Feb 01
Declining Stock and Decent Financials: Is The Market Wrong About Shin Poong Pharm.Co.,Ltd. (KRX:019170)?

We Wouldn't Rely On Shin Poong Pharm.Co.Ltd's (KRX:019170) Statutory Earnings As A Guide

Jan 05
We Wouldn't Rely On Shin Poong Pharm.Co.Ltd's (KRX:019170) Statutory Earnings As A Guide

Is Shin Poong Pharm.Co.Ltd (KRX:019170) Using Too Much Debt?

Dec 10
Is Shin Poong Pharm.Co.Ltd (KRX:019170) Using Too Much Debt?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if A019170's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if A019170's dividend payments have been increasing.


Dividend Yield vs Market

Shinpoong PharmaceuticalLtd Dividend Yield vs Market
How does A019170 dividend yield compare to the market?
SegmentDividend Yield
Company (A019170)0%
Market Bottom 25% (KR)1.2%
Market Top 25% (KR)4.0%
Industry Average (Pharmaceuticals)1.1%
Analyst forecast (A019170) (up to 3 years)n/a

Notable Dividend: Unable to evaluate A019170's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate A019170's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: A019170 is not paying a notable dividend for the KR market.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as A019170 has not reported any payouts.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 14:21
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shinpoong Pharmaceutical Co.,Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution